scholarly journals EORTC-related new drug discovery and development activities: role of the Pharmacology and Molecular Mechanisms Group

2012 ◽  
Vol 10 (1) ◽  
pp. 128-140 ◽  
Author(s):  
G.J. Peters ◽  
E. Chatelut ◽  
A.K. Larsen ◽  
N. Zaffaroni
2020 ◽  
Vol 107 (4) ◽  
pp. 796-805 ◽  
Author(s):  
Daniela J. Conrado ◽  
Sridhar Duvvuri ◽  
Hugo Geerts ◽  
Jackson Burton ◽  
Carla Biesdorf ◽  
...  

2001 ◽  
Vol 21 (5) ◽  
pp. 397-411 ◽  
Author(s):  
Gondi N. Kumar ◽  
Sekhar Surapaneni

2007 ◽  
Vol 24 (5) ◽  
pp. 842-858 ◽  
Author(s):  
Lilian G. Yengi ◽  
Louis Leung ◽  
John Kao

2006 ◽  
Vol 34 (2) ◽  
pp. 313-316 ◽  
Author(s):  
G.P. Belfield ◽  
S.J. Delaney

The discipline of molecular biology has become increasingly important in recent times for the process of drug discovery. We describe the impact of molecular biology across the whole process of drug discovery and development, including (i) the identification and validation of new drug targets, (ii) the development of molecular screens to find new candidate drugs, and (iii) the generation of safety data and competences leading to enhanced clinical efficacy. We also speculate on emerging developments in drug discovery where it seems likely that molecular biology will play an even more vital role in the generation of future therapies.


Sign in / Sign up

Export Citation Format

Share Document